This is a $232,150 firm fixed-price purchase order awarded by the National Institute on Aging (NIA), a civilian federal agency, to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for the delivery of PROMETHION FLOW CELL PACKS, which are a key consumable component of Oxford Nanopore's PromethION sequencing platform. The contract has a period of performance through May 1, 2028. Oxford Nanopore Technologies Inc. is an established federal...
This federal contract award, valued at $22,600, was issued by the National Institute on Aging (NIA), part of the National Institutes of Health (NIH), to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for the procurement of SCIENTIFIC EQUIPMENT - PROMETHION FLOW CELLS, with a completion date of Nov 15, 2024. Oxford Nanopore Technologies is a provider of nanopore-based electronic systems for analyzing single molecules, including DNA, RNA,...
This federal contract award, valued at $44,838.00, was made by the National Institute on Aging (NIA), a civilian agency under the U.S. Department of Health and Human Services, to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The award is for the procurement of Promethion flow cell packs and ligation sequencing kits, which are used in Oxford Nanopore's next-generation genomic sequencing platforms. The contract is a firm fixed-price purchase order with a...
This federal contract award to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, is for the procurement of 8 packs of 4 PromethION flow cells (RNA) at a ceiling value of $21,835.00. The contract is a firm fixed-price purchase order awarded by the National Human Genome Research Institute, a civilian agency within the National Institutes of Health. The contract does not utilize a set-aside designation and has an ultimate completion date of September 26, 2025....
This federal contract award, valued at $75,200.00, was issued by the National Institute on Aging (NIA), a civilian agency under the National Institutes of Health (NIH), to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The award is for the delivery of PromethION Flow Cell Packs (R10.4.1) for an ongoing NIA research project. The contract is a firm-fixed-price purchase order with a completion date of September 14, 2024. The original sources sought notice...
This federal contract award, valued at $21,835.00, was issued by the National Human Genome Research Institute (NHGRI) to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for the delivery of 8 packs of 4 PROMETHION flow cells, which are consumable components used in Oxford Nanopore's genomic sequencing instruments. The contract does not have a set-aside designation and is a firm fixed-price purchase order, with an ultimate completion date of...
This federal contract award, valued at $21,835.00, was issued by the National Human Genome Research Institute (NHGRI) to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for the procurement of 8 packs of 4 PROMETHION flow cell packs (RNA), a product used in next-generation genomic sequencing. The contract has a firm fixed price and an ultimate completion date of November 14, 2025. Oxford Nanopore Technologies Inc. is a prime contractor that...
This is a $24,950 firm fixed-price purchase order awarded by the National Institute on Deafness and Other Communication Disorders (NIDCD), a civilian agency, to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The contract is for a PROMETHION SEQUENCING INSTRUMENT AND REAGENT STARTER PACKAGE, with a performance period ending on May 21, 2026. Oxford Nanopore Technologies Inc. is the prime contractor and there are no subcontractors mentioned. The contract is not...
This federal contract award is for the delivery of PROMETHION FLOW CELL PACKS (RNA) to the National Human Genome Research Institute, which is part of the Department of Health and Human Services National Institutes of Health. The prime contractor is Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company that develops nanopore-based electronic systems for analyzing single molecules including DNA, RNA, and proteins. The contract has a firm fixed price of $11,568.00 and...
This firm fixed-price purchase order was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Oxford Nanopore Technologies, Inc., a foreign-owned, for-profit biotechnology company. The $19,965.00 award is for the delivery of Promethion flow cell packs and related sequencing reagents. This contract has an ultimate completion date of December 30, 2025 and does not utilize any set-aside designations. Oxford Nanopore Technologies provides advanced genomic...